Evidence map›Paper›PMID 37987716›Full record

Observational studyJournal of comparative effectiveness research2024

Real-world assessment of treatment inertia in the management of patients treated for major depressive disorder in the USA.

John J Sheehan, Chris LaVallee, Keshia Maughn, Santosh Balakrishnan, Jacqueline A Pesa, Kruti Joshi, Craig Nelson

Open access · diamondAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of comparative effectiveness research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

John J SheehanJanssen Scientific Affairs, LLC, Titusville, NJ 08560, USA.
Chris LaValleeHealth Outcomes Research, Decision Resources Group, Boston, MA 02116, USA.
Keshia MaughnAnalytics, Decision Resources Group, Boston, MA 02116, USA.
Santosh BalakrishnanAnalytics, Decision Resources Group, Boston, MA 02116, USA.
Jacqueline A PesaJanssen Scientific Affairs, LLC, Titusville, NJ 08560, USA.
Kruti JoshiJanssen Scientific Affairs, LLC, Titusville, NJ 08560, USA.
Craig NelsonDepartment of Psychiatry, University of California San Francisco, San Francisco, CA 94143, USA.
Janssen Scientific Affairs (United States)Janssen (United States) · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Major Depressive DisorderAdolescentAdultAntidepressive AgentsBupropionFemaleHumansMaleMiddle AgedOutpatientsSelective Serotonin Reuptake InhibitorsAntidepressive AgentsBupropionSelective Serotonin Reuptake Inhibitorsdepressive disordermajor depressive disordertreatment inertia

Identifiers

PMID37987716
PMCPMC10842298
OpenAlexW4388861398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.